Tchervenkov J I, Epstein M D, Alexander J W, Schroeder T J
Department of Surgery, University of Cincinnati Medical Center, OH 45267-0558.
Transplantation. 1989 Jan;47(1):177-81. doi: 10.1097/00007890-198901000-00037.
We investigated the effect of donor-specific transfusion given 24 hours pretransplant, a short course of low-dose cyclosporine, and dietary enrichment with the prostaglandin precursor linoleic acid (LA) to see which of the modalities could act synergistically on cardiac allograft survival in a stringent animal model. ACI male rats (RT1a) were used as blood and heart donors, and Lewis male rats (RT1l) were used as recipients. DST alone (1 ml) given 24 hr pretransplant or LA alone started 24 hr pretransplant and given daily p.o. until rejection prolonged cardiac allograft survival slightly but significantly, from 6 to 8 days. CsA alone started at the time of transplant at a dose of 5 mg/kg/day s.c. and given daily for 14 days prolonged cardiac survival to 11.8 days. However, when CsA was started 24 hr pretransplant and continued for two weeks, there was a significantly prolonged allograft survival to 55 days. CsA given together with DST 24 hr pretransplant and continued for two weeks posttransplant significantly prolonged cardiac allograft survival to 80 days and resulted in permanent tolerance in some animals. The addition of LA to a DST and CSA treatment regimen did not further improve allograft survival. CsA blood levels were determined in a separate group of Lewis rats. Three dosages of CsA were administered s.c. for 2 weeks: 2.5 mg/kg/day, 5 mg/kg/day, and 10 mg/kg/day. One injection of the three CsA doses did not achieve what are considered therapeutic levels in man. After 5 days, all three doses of CsA achieved significant blood levels. Significant blood levels were still present one week, but not 3 weeks after CsA was stopped. We conclude that DST given 24 hr before transplant and a 2-week course of low-dose CsA started one day pretransplant have strong synergism in inducing long-term graft survival in this rat model. Linoleic acid started 24 hr pretransplant, together with DST and CsA, did not contribute significantly to graft survival compared with the group given CsA and DST alone. Prolonged heart allograft survival was not due to persistently high CsA levels after the drug was discontinued.
我们研究了移植前24小时给予供体特异性输血、短期低剂量环孢素以及用前列腺素前体亚油酸(LA)进行饮食强化的效果,以观察在一个严格的动物模型中,哪种方式能对心脏同种异体移植存活产生协同作用。雄性ACI大鼠(RT1a)用作血液和心脏供体,雄性Lewis大鼠(RT1l)用作受体。移植前24小时单独给予供体特异性输血(1毫升)或移植前24小时开始单独给予LA并每天口服直至排斥反应,可使心脏同种异体移植存活时间略有但显著延长,从6天延长至8天。单独使用环孢素在移植时开始,剂量为5毫克/千克/天,皮下注射,每天给药14天,可使心脏存活时间延长至11.8天。然而,当环孢素在移植前24小时开始并持续两周时,同种异体移植存活时间显著延长至55天。移植前24小时将环孢素与供体特异性输血一起给予,并在移植后持续两周,可使心脏同种异体移植存活时间显著延长至80天,并使一些动物产生永久耐受性。在供体特异性输血和环孢素治疗方案中加入LA并没有进一步改善同种异体移植存活情况。在另一组Lewis大鼠中测定了环孢素的血药浓度。皮下注射三种剂量的环孢素,持续两周:2.5毫克/千克/天、5毫克/千克/天和10毫克/千克/天。单次注射这三种环孢素剂量并未达到人体中的治疗水平。5天后,所有三种剂量的环孢素都达到了显著的血药浓度。在停止使用环孢素一周后仍存在显著的血药浓度,但三周后则没有。我们得出结论,移植前24小时给予供体特异性输血以及移植前一天开始的为期两周的低剂量环孢素疗程在该大鼠模型中诱导长期移植物存活方面具有很强的协同作用。与单独给予环孢素和供体特异性输血的组相比,移植前24小时开始的亚油酸与供体特异性输血和环孢素一起使用对移植物存活没有显著贡献。心脏同种异体移植存活时间延长并非由于停药后环孢素水平持续升高。